Can concepts from CLL be applied to other liquid and solid tumors?
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Importance of prognostic factors in the treatment of CLL and how to assess them
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
Bone marrow transplant consent: insight into patient motivations